Skip to main content

Veri Medtech (VRHI) Reaches 1.3 million Patient Registrations

Written by Customer Service on . Posted in Public Companies.

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) — Veri Medtech Holdings (OTC Markets: (“VRHI”) (“Veri Medtech”) announced today that it has reached 1.3 million patient registrations.

“2025 will prove to be a transformative year, as we work to strategically position Veri Medtech (VRHI) to be an alternative to current telemedicine providers.  With thousands of new patient registrations per month, via our proprietary healthcare technology platform, Veri Medtech (VRHI) is poised and positioned to continue to capture marketshare as a leading provider for health and wellness prescription and non-prescription products and services, in the estimated $114 billion market for telemedicine, for years to come,” said Sam Adetunji, CEO, Veri Medtech Holdings.

About Veri Medtech (OTC Markets: VRHI): Veri Medtech is a leading provider of health and wellness services and products, via its proprietary healthcare technology platform.  Veri Medtech is strategically positioned to explore untapped opportunities, including the acquisition of complementary healthcare companies. This strategic growth approach allows us to leverage our technological advantage, expanding our offerings to a broader audience. Our successful track record in completing similar acquisitions ensures the swift integration of new patient databases, providing us with an instant avenue for revenue growth and a wider pool of patients open to diverse healthcare opportunities.  For more information, please visit: www.VeriMedTech.com. 

About Global Telemedicine:  The global telemedicine market size was valued at USD 114.98 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.96% from 2024 to 2030.  Telemedicine market growth is being driven by factors such as consolidation across industry, strategic initiatives by key companies, and increasing healthcare consumerism. Furthermore, rising adoption of telemedicine by providers, increasing patient acceptance and consumer demand, and delivery of improved quality of care are expected to contribute to the growth of the telemedicine market over the forecast period. For instance, in May 2021, Walmart Inc. acquired a telehealth company, MeMD. This acquisition is expected to enable Walmart to expand its offerings and provide virtual access to primary, urgent, and behavioral healthcare services nationwide. Source: Grandview Research. https://www.grandviewresearch.com/industry-analysis/telemedicine-industry

About Prescription Products and Services:  Certain products and services available through Veri Medtech can be purchased only with a prescription from a qualified medical provider. To access these products, you must first consult with a medical provider through our proprietary technology platform.  We make this process simple and convenient. Through Veri Medtech, you can access a network of medical providers who can evaluate your specific needs based on your health information, and if appropriate, prescribe treatment.  For more information, please visit: www.VeriMedTech.com. 

Forward Looking Statements: Cautionary Note Regarding Forward-Looking Statements: This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Veri Medtech (OTC: “VRHI”) and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.

CONTACT: Press Release Contact: pr@verimedtech.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.